Hsf1 Activation Inhibits Rapamycin Resistance and TOR Signaling in Yeast Revealed by Combined Proteomic and Genetic Analysis

Sricharan Bandhakavi, Hongwei Xie, Brennon O'Callaghan et al. · 2008

Read Hsf1 Activation Inhibits Rapamycin Resistance and TOR Signaling in Yeast Revealed by Combined Proteomic and Genetic Analysis by Sricharan Bandhakavi, Hongwei Xie, Brennon O'Callaghan et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001598.txt.

Description

Sricharan Bandhakavi and co-authors wrote a 2008 PLOS ONE study on yeast that resists a key drug. The drug rapamycin blocks the TOR path, a master growth switch in cells. Some yeast shrug the drug off. The team combined protein counts with gene tests to find how. They flagged a heat shock factor as a key player.

Switching that factor on both curbed resistance and dimmed TOR signals. That ties stress reply to growth control in a new way. TOR is a cancer drug target in people, so yeast clues carry weight. They may hint at how tumors dodge TOR drugs too.

Catalog record

CREATORSricharan Bandhakavi, Hongwei Xie, Brennon O'Callaghan et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE70 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001598

Browse the full library · About the Tower of Babel